Gabriel S. Morris - 14 Aug 2023 Form 4/A - Amendment Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CFO, Director
Signature
/s/ Gabriel Morris
Issuer symbol
IMMX
Transactions as of
14 Aug 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
09 Nov 2023, 19:57:06 UTC
Date Of Original Report
14 Aug 2023
Previous filing
14 Aug 2023
Next filing
14 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Options Award $0 +293,000 $0.000000 293,000 14 Aug 2023 Common Stock 293,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest monthly over 48 months from the date of grant.